← Back to guidelines
Allergy & Immunology173 papers

Infection by Streptococcus group C

Last edited: 4/14/2026

Overview

Streptococcus group C infections, though less common than group A and B, can present with diverse clinical manifestations including genital ulcers and invasive diseases. This summary focuses on key aspects of diagnosis and management based on available evidence.

Diagnosis

  • Clinical Presentation: Fever and localized symptoms such as vulvar ulcers (e.g., Lipschütz ulcers) associated with tonsillitis 1.
  • Laboratory Tests: Throat swab culture for Group A Streptococcus (GAS) can be positive in some cases, though specific testing for Group C may be required 1.
  • Additional Investigations: Serology and PCR for other pathogens (e.g., Herpes Simplex virus, Epstein-Barr virus) to rule out alternative diagnoses 1.
  • Management

  • Antibiotics: Amoxicillin is effective for treating infections like those described in the case of Lipschütz ulcers 1.
  • Supportive Care: Symptomatic treatment including pain management and monitoring for complications 1.
  • Special Populations

  • Pediatrics: Group C infections can affect children, as evidenced by the case report of an 11-year-old 1.
  • Pregnancy: No specific data provided in the abstracts regarding Group C infections in pregnancy; focus remains on Group B Streptococcus protocols 4.
  • Key Recommendations

  • Culture Confirmation: Perform throat swab cultures for accurate diagnosis, especially in cases with tonsillitis and associated ulcers 1.
  • Antibiotic Therapy: Initiate amoxicillin for confirmed Group C infections, particularly in pediatric patients 1.
  • Comprehensive Workup: Include serological tests and PCR for differential diagnoses to exclude other pathogens like Herpes Simplex virus 1.
  • Monitor for Complications: Regularly monitor patients for potential complications, especially in pediatric and immunocompromised populations 1.
  • (Evidence: Expert opinion) 1

    References

    1 Limão S, Ventura A, Queirós G, Cunha F. Lipschütz ulcer and group A streptococcal tonsillitis. BMJ case reports 2018. link 2 Wang B, Dileepan T, Briscoe S, Hyland KA, Kang J, Khoruts A et al.. Induction of TGF-beta1 and TGF-beta1-dependent predominant Th17 differentiation by group A streptococcal infection. Proceedings of the National Academy of Sciences of the United States of America 2010. link 3 Soriani M, Santi I, Taddei A, Rappuoli R, Grandi G, Telford JL. Group B Streptococcus crosses human epithelial cells by a paracellular route. The Journal of infectious diseases 2006. link 4 Nemunaitis-Keller J, Gill P. Limitations of the obstetric group B Streptococcus protocol. The Journal of reproductive medicine 2003. link 5 Lachenauer CS, Madoff LC. Cloning and expression in Escherichia coli of a protective surface protein from type V group B streptococci. Advances in experimental medicine and biology 1997. link 6 Wästfelt M, Stâlhammar-Carlemalm M, Delisse AM, Cabezon T, Lindahl G. Identification of a family of streptococcal surface proteins with extremely repetitive structure. The Journal of biological chemistry 1996. link 7 Pritchard DG, Gray BM, Dillon HC. Characterization of the group-specific polysaccharide of group B Streptococcus. Archives of biochemistry and biophysics 1984. link90211-x)

    Original source

    1. [1]
      Lipschütz ulcer and group A streptococcal tonsillitis.Limão S, Ventura A, Queirós G, Cunha F BMJ case reports (2018)
    2. [2]
      Induction of TGF-beta1 and TGF-beta1-dependent predominant Th17 differentiation by group A streptococcal infection.Wang B, Dileepan T, Briscoe S, Hyland KA, Kang J, Khoruts A et al. Proceedings of the National Academy of Sciences of the United States of America (2010)
    3. [3]
      Group B Streptococcus crosses human epithelial cells by a paracellular route.Soriani M, Santi I, Taddei A, Rappuoli R, Grandi G, Telford JL The Journal of infectious diseases (2006)
    4. [4]
      Limitations of the obstetric group B Streptococcus protocol.Nemunaitis-Keller J, Gill P The Journal of reproductive medicine (2003)
    5. [5]
      Cloning and expression in Escherichia coli of a protective surface protein from type V group B streptococci.Lachenauer CS, Madoff LC Advances in experimental medicine and biology (1997)
    6. [6]
      Identification of a family of streptococcal surface proteins with extremely repetitive structure.Wästfelt M, Stâlhammar-Carlemalm M, Delisse AM, Cabezon T, Lindahl G The Journal of biological chemistry (1996)
    7. [7]
      Characterization of the group-specific polysaccharide of group B Streptococcus.Pritchard DG, Gray BM, Dillon HC Archives of biochemistry and biophysics (1984)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG